Skip to content
CR

Crane Co

Crane Co Q1 FY2025 earnings call

April 30, 2025 · fiscal period ended 2025-03

EPS · actual vs est

/

Revenue · actual vs est

/
Ask about this call

Summary

Generated 2025-04-30

Management highlights

Management Statement and Operational Highlights

  • Strategic Focus: Emphasized honing strategic thinking, reacting to fast-changing events, and executing in a dynamic environment, confident in emerging stronger post-adversity.
  • Segment Updates: Aerospace & Electronics sees strong demand in commercial and defense, with new opportunities won (e.g., XM30 program, Bell V-280 contracts). Process Flow Technologies repositioned around core end markets (chemical, pharmaceuticals, etc.), investing in growth and active in M&A with a $1.5 billion M&A capacity.
  • Tariff Exposure: About 7-8% of COGS from direct US imports, 3-4% from intercompany sales. Expect to offset tariff impact via price and productivity.
  • Investor Day: Highlighted advanced high power conversion technologies at Fort Walton Beach facility for defense applications.
  • Senior Leadership Conference: Focus on growth, commercial execution, strategy development, and sharing best practices across the company.
View in transcript ↓

Segment performance

Segment Performance

  • Aerospace & Electronics: Generated sales of $249 million in the quarter, a 10% increase with all growth organic. Record backlog reached $960 million, up 21% year-over-year and 11% sequentially. Adjusted segment margin was 26%, a record high, up 360 basis points from the prior year. Core sales growth for the year is expected to be mid to high-single digits.
  • Process Flow Technologies: Achieved sales of $309 million, up 9% in the quarter. Driven by 5% core sales growth and a 5% benefit from the CryoWorks and Technifab acquisitions, offset by unfavorable foreign exchange. Core FX-neutral backlog decreased 6% year-over-year, while core FX neutral orders increased 2% year-over-year and 10% sequentially. The segment anticipates positive core growth sales for the year.
View in transcript ↓

Guidance

Guidance

  • Reaffirmed full-year 2025 adjusted EPS outlook in the range of $5.30 to $5.60, based on current economic conditions. Assumptions include tariffs continuing throughout the balance of the year. Will adjust outlook if trade policy or demand changes occur.
View in transcript ↓

Risks

Risks

  • Tariff impacts on COGS if not mitigated.
  • Supply chain disruptions potentially affecting deliveries and projects.
  • Economic uncertainties impacting demand in certain regions, particularly in chemical markets.
View in transcript ↓

Q&A highlights

Question and Answer

Q: Clarity on updated guidance and price contribution A: Price expected to offset majority of tariff impact, around 3% overall, more in Process Flow Technologies. Backlog growth is broad-based, including multiyear orders in defense.

Q: Defense program growth drivers A: Munitions replenishment, aging military upgrades, electrification are key themes driving growth in defense programs.

Q: Growth split in Aerospace & Electronics A: Roughly 50-50 between volume and price growth in the quarter.

Q: COMAC and tariffs A: COMAC is still taking deliveries for C919, on track with ramp-up, and aftermarket is strong.

Q: Supply chain risk A: Process Flow Technologies supply chain is stable; Aerospace & Electronics is seeing slight lead time extensions but no major disruption.

Q: M&A activity A: Active in M&A, traveling for due diligence on multiple acquisitions, hopeful for announcements in 2025

View in transcript ↓

Key numbers

Reported versus consensus

Earnings calendar feed

MetricReportedConsensusDeltaPrior year
EPS
Revenue

Transcript

April 30, 2025

Full transcript unavailable for redistribution

The structured summary above covers the available call sections. Full transcript text is not included on this page.

Continue exploring

Prior quarters

This page presents the stored structured earnings-call summary and deterministic earnings calendar values. How this is generated. For informational purposes only; not investment advice.